The co-founders of Machine Bio, a Claremont-based biotechnology startup, have gotten pretty good at innovating radical solutions for their industry here on earth. But soon, their technology will be tested in less-charted territory: space. Machine Bio was recently awarded the Technology in Space Prize, which includes up to $500,000 in grant funding. It also means their technology, which revolutionizes protein synthesis, will be shuttled off for research in the U.S. National Laboratory aboard the International Space Station.